These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 12702520)

  • 1. Adjuvant therapy in pancreatic cancer: historical and current perspectives.
    Neoptolemos JP; Cunningham D; Friess H; Bassi C; Stocken DD; Tait DM; Dunn JA; Dervenis C; Lacaine F; Hickey H; Raraty MG; Ghaneh P; Büchler MW
    Ann Oncol; 2003 May; 14(5):675-92. PubMed ID: 12702520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New techniques and agents in the adjuvant therapy of pancreatic cancer.
    Raraty MG; Magee CJ; Ghaneh P; Neoptolemos JP
    Acta Oncol; 2002; 41(7-8):582-95. PubMed ID: 14651201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conclusions from the European Study Group for Pancreatic Cancer adjuvant trial of chemoradiotherapy and chemotherapy for pancreatic cancer.
    Ghaneh P; Neoptolemos JP
    Surg Oncol Clin N Am; 2004 Oct; 13(4):567-87, vii-viii. PubMed ID: 15350935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adjuvant chemoradiotherapy and chemotherapy in resectable pancreatic cancer: a randomised controlled trial.
    Neoptolemos JP; Dunn JA; Stocken DD; Almond J; Link K; Beger H; Bassi C; Falconi M; Pederzoli P; Dervenis C; Fernandez-Cruz L; Lacaine F; Pap A; Spooner D; Kerr DJ; Friess H; Büchler MW;
    Lancet; 2001 Nov; 358(9293):1576-85. PubMed ID: 11716884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A multicenter randomized controlled trial to evaluate the effect of adjuvant cisplatin and 5-fluorouracil therapy after curative resection in cases of pancreatic cancer.
    Kosuge T; Kiuchi T; Mukai K; Kakizoe T;
    Jpn J Clin Oncol; 2006 Mar; 36(3):159-65. PubMed ID: 16490736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surgery and multimodal treatments in pancreatic cancer--a review on the basis of future multimodal treatment concepts.
    Link KH; Leder G; Formentini A; Fortnagel G; Kornmann M; Schatz M; Beger HG
    Gan To Kagaku Ryoho; 1999 Jan; 26(1):10-40. PubMed ID: 9987495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjuvant therapy for pancreatic cancer.
    Sultana A; Cox T; Ghaneh P; Neoptolemos JP
    Recent Results Cancer Res; 2012; 196():65-88. PubMed ID: 23129367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New Techniques and Agents in the Adjuvant Therapy of Pancreatic Cancer.
    Raraty MGT; Magee CJ; Ghaneh P; Neoptolemos JP
    Acta Oncol; 2002; 41(7-8):582-595. PubMed ID: 28758860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemotherapy for pancreatic cancer.
    Springfeld C; Jäger D; Büchler MW; Strobel O; Hackert T; Palmer DH; Neoptolemos JP
    Presse Med; 2019 Mar; 48(3 Pt 2):e159-e174. PubMed ID: 30879894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adjuvant therapy for pancreatic cancer.
    Ghaneh P; Slavin J; Sutton R; Neoptolemos JP
    Swiss Surg; 2000; 6(5):289-95. PubMed ID: 11077498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical study of the month. Adjuvant radio-chemotherapy and chemotherapy following curative resection of pancreatic cancer: results of the randomized trial ESPAC-1].
    Polus M; Jerusalem G; Sautois B; Silvestre RM; Collette MY; Closon MT; Fillet G
    Rev Med Liege; 2002 Feb; 57(2):119-22. PubMed ID: 11942178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluating the Impact of ESPAC-1 on Shifting the Paradigm of Pancreatic Cancer Treatment.
    Winer LK; Cortez AR; Ahmad SA; Wima K; Olowokure O; Latif T; Kharofa J; Patel SH
    J Surg Res; 2021 Mar; 259():442-450. PubMed ID: 33059910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adjuvant therapy in pancreatic cancer.
    Thomas A; Dajani K; Neoptolemos JP; Ghaneh P
    Dig Dis; 2010; 28(4-5):684-92. PubMed ID: 21088421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of adjuvant therapy for pancreatic cancer.
    Magee CJ; Ghaneh P; Hartley M; Sutton R; Neoptolemos JP
    Expert Opin Investig Drugs; 2002 Jan; 11(1):87-107. PubMed ID: 11772324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resection and radiochemotherapy of pancreatic cancer--the future?
    Link KH; Formentini A; Leder G; Fortnagel G; Sartori N; Schatz M; Beger HG
    Langenbecks Arch Surg; 1998 Apr; 383(2):134-44. PubMed ID: 9641886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ESPAC-1 trial progress report: the European randomized adjuvant study comparing radiochemotherapy, 6 months chemotherapy and combination therapy versus observation in pancreatic cancer.
    Neoptolemos JP; Kerr DJ; Beger H; Link K; Pederzoli P; Bassi C; Dervenis C; Fernandez-Cruz L; Laçaine F; Friess H; Büchler M
    Digestion; 1997; 58(6):570-7. PubMed ID: 9438604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Longitudinal quality of life data can provide insights on the impact of adjuvant treatment for pancreatic cancer-Subset analysis of the ESPAC-1 data.
    Carter R; Stocken DD; Ghaneh P; Bramhall SR; Olah A; Kelemen D; Bassi C; Friess H; Dervenis C; Spry N; Büchler MW; Neoptolemos JP;
    Int J Cancer; 2009 Jun; 124(12):2960-5. PubMed ID: 19330830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The case for adjuvant chemotherapy in pancreatic cancer.
    Ghaneh P; Sultana A; Shore S; Stocken D; Neoptolemos J
    Best Pract Res Clin Gastroenterol; 2006 Apr; 20(2):383-401. PubMed ID: 16549334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progress report. A randomized multicenter European study comparing adjuvant radiotherapy, 6-mo chemotherapy, and combination therapy vs no-adjuvant treatment in resectable pancreatic cancer (ESPAC-1).
    Neoptolemos JP; Baker P; Beger H; Link K; Pederzoli P; Bassi C; Dervenis C; Friess H; Büchler M
    Int J Pancreatol; 1997 Apr; 21(2):97-104. PubMed ID: 9209950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overall survival of patients with recurrent pancreatic cancer treated with systemic therapy: a retrospective study.
    Gbolahan OB; Tong Y; Sehdev A; O'Neil B; Shahda S
    BMC Cancer; 2019 May; 19(1):468. PubMed ID: 31101022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.